Literature DB >> 31555678

Improving our understanding of breast cancer tumorigenesis across ethnicities.

Michael J McKay1, Melissa Southey2.   

Abstract

Entities:  

Year:  2019        PMID： 31555678      PMCID： PMC6736823          DOI： 10.21037/atm.2019.07.14

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  7 in total

1.  Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer.

Authors:  Hua Yuan; Jiuan Chen; Yiqiang Liu; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Zhaoqing Fan; Tie Fan; Benyao Lin; Yuntao Xie
Journal:  Clin Cancer Res       Date:  2015-05-15       Impact factor: 12.531

2.  Concordance of genomic alterations between primary and recurrent breast cancer.

Authors:  Funda Meric-Bernstam; Garrett M Frampton; Jaime Ferrer-Lozano; Roman Yelensky; Jose A Pérez-Fidalgo; Ying Wang; Gary A Palmer; Jeffrey S Ross; Vincent A Miller; Xiaoping Su; Pilar Eroles; Juan Antonio Barrera; Octavio Burgues; Ana M Lluch; Xiaofeng Zheng; Aysegul Sahin; Philip J Stephens; Gordon B Mills; Maureen T Cronin; Ana M Gonzalez-Angulo
Journal:  Mol Cancer Ther       Date:  2014-03-07       Impact factor: 6.261

3.  Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

Authors:  Gabriel N Hortobagyi; David Chen; Martine Piccart; Hope S Rugo; Howard A Burris; Kathleen I Pritchard; Mario Campone; Shinzaburo Noguchi; Alejandra T Perez; Ines Deleu; Mikhail Shtivelband; Norikazu Masuda; Shaker Dakhil; Ian Anderson; Douglas M Robinson; Wei He; Abhishek Garg; E Robert McDonald; Hans Bitter; Alan Huang; Tetiana Taran; Thomas Bachelot; Fabienne Lebrun; David Lebwohl; José Baselga
Journal:  J Clin Oncol       Date:  2015-10-26       Impact factor: 44.544

4.  Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.

Authors:  Guochun Zhang; Yulei Wang; Bo Chen; Liping Guo; Li Cao; Chongyang Ren; Lingzhu Wen; Kai Li; Minghan Jia; Cheukfai Li; Hsiaopei Mok; Xiaoqing Chen; Guangnan Wei; Jiali Lin; Zhou Zhang; Ting Hou; Han Han-Zhang; Chenglin Liu; Hao Liu; Jing Liu; Charles M Balch; Funda Meric-Bernstam; Ning Liao
Journal:  Ann Transl Med       Date:  2019-04

5.  Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.

Authors:  Guoli Li; Xinwu Guo; Ming Chen; Lili Tang; Hui Jiang; Julia X Day; Yueliang Xie; Limin Peng; Xunxun Xu; Jinliang Li; Shouman Wang; Zhi Xiao; Lizhong Dai; Jun Wang
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

6.  Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients.

Authors:  Ling Deng; Xuehua Zhu; Yun Sun; Jiemin Wang; Xiaorong Zhong; Jiayuan Li; Min Hu; Hong Zheng
Journal:  Cancer Res Treat       Date:  2018-03-15       Impact factor: 4.679

7.  COSMIC: the Catalogue Of Somatic Mutations In Cancer.

Authors:  John G Tate; Sally Bamford; Harry C Jubb; Zbyslaw Sondka; David M Beare; Nidhi Bindal; Harry Boutselakis; Charlotte G Cole; Celestino Creatore; Elisabeth Dawson; Peter Fish; Bhavana Harsha; Charlie Hathaway; Steve C Jupe; Chai Yin Kok; Kate Noble; Laura Ponting; Christopher C Ramshaw; Claire E Rye; Helen E Speedy; Ray Stefancsik; Sam L Thompson; Shicai Wang; Sari Ward; Peter J Campbell; Simon A Forbes
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.